Abstract
A high proportion of patients with drug-resistant temporal lobe epilepsy (TLE) show focal relative hypometabolism in the region of the epileptogenic zone on [18F]-Fluorodeoxyglucose positron emission tomography (FDG PET). However, whether focal (hypo)metabolism changes over time has not been well studied. We analysed repeated [18F]-FDG PET scans of patients with TLE to determine longitudinal changes in glucose metabolism. Adults (n = 16; 9 female, 7 male) diagnosed with drug resistant chronic TLE were assessed. Each patient had two [18F]-FDG PET scans that were 2–95 months apart. Region-of-interest analysis was performed on MR images onto which PET scans were coregistered to determine the relative [18F]-FDG uptake (normalised to pons) in the bilateral hippocampi and temporal lobes. Statistical Parametric Mapping analysis investigated global voxel-wise changes in relative metabolism between timepoints. Normalised [18F]-FDG uptake did not change with time in the ipsilateral (baseline 1.14 ± 0.03, follow-up 1.19 ± -0.04) or contralateral hippocampus (baseline 1.18 ± 0.03, follow-up 1.19 ± 0.03). Uptake in the temporal neocortex also remained stable (ipsilateral baseline 1.35 ± 0.03, follow-up 1.30 ± 0.04; contralateral baseline 1.38 ± 0.04, follow-up 1.33 ± 0.03). The was no relationship between change in uptake on the repeated scans and the time between the scans. SPM analysis showed increases in metabolism in the ipsilateral temporal lobe in 2/16 patients. No areas of decreased metabolism concordant to the epileptogenic zone were identified. [18F]-FDG uptake showed no significant changes over time in patients with drug-resistant TLE. This suggests that repeating FDG-PET scans in patients with subtle or no hypometabolism is of low clinical yield.
Similar content being viewed by others
Data availability
Data included in this study is patients’ clinical data and is therefore not publicly available.
Code availability
Not applicable.
References
Alvim, M. K., Coan, A. C., Campos, B. M., Yasuda, C. L., Oliveira, M. C., Morita, M. E., & Cendes, F. (2016). Progression of gray matter atrophy in seizure-free patients with temporal lobe epilepsy. Epilepsia, 57(4), 621–629. https://doi.org/10.1111/epi.13334
Benedek, K., Juhasz, C., Chugani, D. C., Muzik, O., & Chugani, H. T. (2006). Longitudinal changes in cortical glucose hypometabolism in children with intractable epilepsy. Journal of Child Neurology, 21(1), 26–31. https://doi.org/10.1177/08830738060210011101
Bernhardt, B. C., Kim, H., & Bernasconi, N. (2013). Patterns of subregional mesiotemporal disease progression in temporal lobe epilepsy. Neurology, 81(21), 1840–1847. https://doi.org/10.1212/01.wnl.0000436069.20513.92
Bernhardt, B. C., Worsley, K. J., Kim, H., Evans, A. C., Bernasconi, A., & Bernasconi, N. (2009). Longitudinal and cross-sectional analysis of atrophy in pharmacoresistant temporal lobe epilepsy. Neurology, 72(20), 1747–1754. https://doi.org/10.1212/01.wnl.0000345969.57574.f5
Carne, R. P., O'Brien, T. J., Kilpatrick, C. J., MacGregor, L. R., Hicks, R. J., Murphy, M. A., . . . Cook, M. J. (2004). MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndrome. Brain, 127(Pt 10), 2276-2285. https://doi.org/10.1093/brain/awh257
Chugani, H. T., Mazziotta, J. C., Engel, J., Jr., & Phelps, M. E. (1987). The Lennox-Gastaut syndrome: Metabolic subtypes determined by 2-deoxy-2[18F]fluoro-D-glucose positron emission tomography. Annals of Neurology, 21(1), 4–13. https://doi.org/10.1002/ana.410210104
Conz, L., Morita, M. E., Coan, A. C., Kobayashi, E., Yasuda, C. L., Pereira, A. R., . . . Cendes, F. (2011). Longitudinal MRI volumetric evaluation in patients with familial mesial temporal lobe epilepsy. Frontiers in Neurology, 2, 5. https://doi.org/10.3389/fneur.2011.00005
Engel, J., Jr. (1984). The use of positron emission tomographic scanning in epilepsy. Annals of Neurology, 15(Suppl), S180-191. https://doi.org/10.1002/ana.410150735
Engel, J., Jr., Henry, T. R., Risinger, M. W., Mazziotta, J. C., Sutherling, W. W., Levesque, M. F., & Phelps, M. E. (1990). Presurgical evaluation for partial epilepsy: Relative contributions of chronic depth-electrode recordings versus FDG-PET and scalp-sphenoidal ictal EEG. Neurology, 40(11), 1670–1677. https://doi.org/10.1212/wnl.40.11.1670
Fuerst, D., Shah, J., Shah, A., & Watson, C. (2003). Hippocampal sclerosis is a progressive disorder: A longitudinal volumetric MRI study. Annals of Neurology, 53(3), 413–416. https://doi.org/10.1002/ana.10509
Gaillard, W. D., Bhatia, S., Bookheimer, S. Y., Fazilat, S., Sato, S., & Theodore, W. H. (1995). FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy. Neurology, 45(1), 123–126. https://doi.org/10.1212/wnl.45.1.123
Gaillard, W. D., Kopylev, L., Weinstein, S., Conry, J., Pearl, P. L., Spanaki, M. V., . . . Theodore, W. H. (2002). Low incidence of abnormal (18)FDG-PET in children with new-onset partial epilepsy: a prospective study. Neurology, 58(5), 717-722. https://doi.org/10.1212/wnl.58.5.717
Galovic, M., van Dooren, V. Q. H., Postma, T., Vos, S. B., Caciagli, L., Borzi, G., . . . Koepp, M. J. (2019). Progressive Cortical Thinning in Patients With Focal Epilepsy. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2019.1708
Goncalves Pereira, P. M., Insausti, R., Artacho-Perula, E., Salmenpera, T., Kalviainen, R., & Pitkanen, A. (2005). MR volumetric analysis of the piriform cortex and cortical amygdala in drug-refractory temporal lobe epilepsy. AJNR. American Journal of Neuroradiology, 26(2), 319–332.
Jokeit, H., Ebner, A., Arnold, S., Schuller, M., Antke, C., Huang, Y., . . . Witte, O. W. (1999). Bilateral reductions of hippocampal volume, glucose metabolism, and wada hemispheric memory performance are related to the duration of mesial temporal lobe epilepsy. Journal of Neurology, 246(10), 926-933. https://doi.org/10.1007/s004150050484
Jupp, B., Williams, J., Binns, D., Hicks, R. J., Cardamone, L., Jones, N., . . . O'Brien, T. J. (2012). Hypometabolism precedes limbic atrophy and spontaneous recurrent seizures in a rat model of TLE. Epilepsia, 53(7), 1233-1244. https://doi.org/10.1111/j.1528-1167.2012.03525.x
Liu, R. S., Lemieux, L., Bell, G. S., Sisodiya, S. M., Bartlett, P. A., Shorvon, S. D., . . . Duncan, J. S. (2002). The structural consequences of newly diagnosed seizures. Annals of Neurology, 52(5), 573-580. https://doi.org/10.1002/ana.10338
Liu, Y. R., Cardamone, L., Hogan, R. E., Gregoire, M. C., Williams, J. P., Hicks, R. J., . . . Bouilleret, V. (2010). Progressive metabolic and structural cerebral perturbations after traumatic brain injury: an in vivo imaging study in the rat. Journal of Nuclear Medicine, 51(11), 1788-1795. https://doi.org/10.2967/jnumed.110.078626
Nightscales, R., McCartney, L., Auvrez, C., Tao, G., Barnard, S., Malpas, C. B., . . . O'Brien, T. J. (2020). Mortality in patients with psychogenic nonepileptic seizures. Neurology, 95(6), e643-e652. https://doi.org/10.1212/WNL.0000000000009855
O'Brien, T. J., Hicks, R. J., Ware, R., Binns, D. S., Murphy, M., & Cook, M. J. (2001). The utility of a 3-dimensional, large-field-of-view, sodium iodide crystal--based PET scanner in the presurgical evaluation of partial epilepsy. Journal of Nuclear Medicine, 42(8), 1158-1165
O’Brien, T. J., Miles, K., Ware, R., Cook, M. J., Binns, D. S., & Hicks, R. J. (2008). The cost-effective use of 18F-FDG PET in the presurgical evaluation of medically refractory focal epilepsy. Journal of Nuclear Medicine, 49(6), 931–937. https://doi.org/10.2967/jnumed.107.048207
Sakaguchi, Y., Kidokoro, H., Ogawa, C., Okai, Y., Ito, Y., Yamamoto, H., . . . Natsume, J. (2018). Longitudinal Findings of MRI and PET in West Syndrome with Subtle Focal Cortical Dysplasia. AJNR. American Journal of Neuroradiology, 39(10), 1932-1937. https://doi.org/10.3174/ajnr.A5772
Shukla, G., & Prasad, A. N. (2012). Natural history of temporal lobe epilepsy: Antecedents and progression. Epilepsy Research and Treatment, 2012, 195073. https://doi.org/10.1155/2012/195073
Spencer, S. S. (1994). The relative contributions of MRI, SPECT, and PET imaging in epilepsy. Epilepsia, 35(Suppl 6), S72-89. https://doi.org/10.1111/j.1528-1157.1994.tb05990.x
Stephen, L. J., Kwan, P., & Brodie, M. J. (2001). Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment? Epilepsia, 42(3), 357–362. https://doi.org/10.1046/j.1528-1157.2001.29000.x
Theodore, W. H. (2003). Magnetic Resonance Imaging of Familial Temporal Lobe Epilepsy. Epilepsy Currents, 3(2), 42–43. https://doi.org/10.1046/j.1535-7597.2003.03203.x
Theodore, W. H., Schulman, E. A., & Porter, R. J. (1983). Intractable seizures: Long-term follow-up after prolonged inpatient treatment in an epilepsy unit. Epilepsia, 24(3), 336–343. https://doi.org/10.1111/j.1528-1157.1983.tb04897.x
Vinton, A. B., Carne, R., Hicks, R. J., Desmond, P. M., Kilpatrick, C., Kaye, A. H., & O’Brien, T. J. (2007). The extent of resection of FDG-PET hypometabolism relates to outcome of temporal lobectomy. Brain, 130(Pt 2), 548–560. https://doi.org/10.1093/brain/awl232
Vivash, L., Gregoire, M. C., Lau, E. W., Ware, R. E., Binns, D., Roselt, P., . . . O'Brien, T. J. (2013). 18F-flumazenil: a gamma-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy. Journal of Nuclear Medicine, 54(8), 1270-1277. https://doi.org/10.2967/jnumed.112.107359
Funding
This project was not supported by any specific grant or other external party. PK is supported by a Medical Research Future Fund Fellowship (MRF1136427).
Author information
Authors and Affiliations
Contributions
CS drafted the manuscript. CS and BS were responsible for data collection, analysis and interpretation. RH supervised the FDG-PET image acquisitions and contributed to data interpretation. PK and TOB contributed to data analysis and interpretation. LV conceived the study and contributed to data analysis and interpretation. All authors edited the manuscript and approved the final submitted version.
Corresponding author
Ethics declarations
Ethics approval
This study was approved by the Melbourne Health Human Research Ethics Committee (QA2012044). The study was conducted in accordance with this approval and ICH GCP.
Consent to participate
In accordance with the HREC approval, specific consent to participate was not sought from patients.
Consent for publication
Not applicable.
Conflict of interest
The authors have no conflicts to declare.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sharpe, C., Sinclair, B., Kwan, P. et al. Longitudinal changes of focal cortical glucose hypometabolism in adults with chronic drug resistant temporal lobe epilepsy. Brain Imaging and Behavior 15, 2795–2803 (2021). https://doi.org/10.1007/s11682-021-00576-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11682-021-00576-8